0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Country adoption of WHO 2019 guidance on HIV testing strategies and algorithms: a policy review across the WHO African region

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          In 2019, the WHO released guidelines on HIV testing service (HTS). We aim to assess the adoption of six of these recommendations on HIV testing strategies among African countries.

          Design

          Policy review.

          Setting

          47 countries within the WHO African region.

          Participants

          National HTS policies from the WHO African region as of December 2021.

          Primary and secondary outcome measures: Uptake of WHO recommendations across national HTS policies including the standard three-test strategy; discontinuation of a tiebreaker test to rule in HIV infection; discontinuation of western blotting (WB) for HIV diagnosis; retesting prior to antiretroviral treatment (ART) initiation and the use of dual HIV/syphilis rapid diagnostic tests (RDTs) in antenatal care. Country policy adoption was assessed on a continuum, based on varying levels of complete adoption.

          Results

          National policies were reviewed for 96% (n=45/47) of countries in the WHO African region, 38% (n=18) were published before 2019 and 60% (n=28) adopted WHO guidance. Among countries that had not fully adopted WHO guidance, not yet adopting a three-test strategy was the most common reason for misalignment (45%, 21/47); of which 31% and 22% were in low-prevalence (<5%) and high-prevalence (≥5%) countries, respectively. Ten policies (21%) recommended the use of WB and 49% (n=23) recommended retesting before ART initiation. Dual HIV/syphilis RDTs were recommended in 45% (n=21/47) of policies.

          Conclusions

          Many countries in the African region have adopted WHO-recommended HIV testing strategies; however, efforts are still needed to fully adopt WHO guidance. Countries should accelerate their efforts to adopt and implement a three-test strategy, retesting prior to ART initiation and the use of dual HIV/syphilis RDTs.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Never the twain shall meet? - a comparison of implementation science and policy implementation research

          Background Many of society’s health problems require research-based knowledge acted on by healthcare practitioners together with implementation of political measures from governmental agencies. However, there has been limited knowledge exchange between implementation science and policy implementation research, which has been conducted since the early 1970s. Based on a narrative review of selective literature on implementation science and policy implementation research, the aim of this paper is to describe the characteristics of policy implementation research, analyze key similarities and differences between this field and implementation science, and discuss how knowledge assembled in policy implementation research could inform implementation science. Discussion Following a brief overview of policy implementation research, several aspects of the two fields were described and compared: the purpose and origins of the research; the characteristics of the research; the development and use of theory; determinants of change (independent variables); and the impact of implementation (dependent variables). The comparative analysis showed that there are many similarities between the two fields, yet there are also profound differences. Still, important learning may be derived from several aspects of policy implementation research, including issues related to the influence of the context of implementation and the values and norms of the implementers (the healthcare practitioners) on implementation processes. Relevant research on various associated policy topics, including The Advocacy Coalition Framework, Governance Theory, and Institutional Theory, may also contribute to improved understanding of the difficulties of implementing evidence in healthcare. Implementation science is at a relatively early stage of development, and advancement of the field would benefit from accounting for knowledge beyond the parameters of the immediate implementation science literature. Summary There are many common issues in policy implementation research and implementation science. Research in both fields deals with the challenges of translating intentions into desired changes. Important learning may be derived from several aspects of policy implementation research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tools developed and disseminated by guideline producers to promote the uptake of their guidelines.

            The uptake of clinical practice guidelines (CPGs) is inconsistent, despite their potential to improve the quality of health care and patient outcomes. Some guideline producers have addressed this problem by developing tools to encourage faster adoption of new guidelines. This review focuses on the effectiveness of tools developed and disseminated by guideline producers to improve the uptake of their CPGs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Achieving the 95 95 95 targets for all: A pathway to ending AIDS

              In December 2020, UNAIDS released a new set of ambitious targets calling for 95% of all people living with HIV to know their HIV status, 95% of all people with diagnosed HIV infection to receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy to have viral suppression by 2025. Adopted by United Nations Member states in June 2021 as part of the new Political Declaration on HIV and AIDS, these targets, combined with ambitious primary prevention targets and focused attention to supporting enablers, aim to bridge inequalities in treatment coverage and outcomes and accelerate HIV incidence reductions by focusing on progress in all sub-populations, age groups and geographic settings. Here we summarise the evidence and decisions underpinning the new global targets.
                Bookmark

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2023
                28 December 2023
                : 13
                : 12
                : e071198
                Affiliations
                [1 ]departmentGlobal HIV, Hepatitis, and STI Programmes , Ringgold_3489World Health Organization , Geneva, Switzerland
                [2 ]Ringgold_93781World Health Organization Regional Office for Africa , Bamako, Mali
                [3 ]departmentInter-country support team for Central Africa , Ringgold_93781World Health Organization Regional Office for Africa , Libreville, Gabon
                [4 ]departmentInter-country support team for Western and Central Africa , Ringgold_93781World Health Organization Regional Office for Africa , Ouagadougou, Burkina Faso
                [5 ]departmentInter-country support team for Eastern and Southern Africa , Ringgold_93781World Health Organization Regional Office for Africa , Harare, Zimbabwe
                [6 ]Ringgold_93781World Health Organization Regional Office for Africa , Brazzaville, Congo
                [7 ]departmentRegulation and Prequalification , Ringgold_3489World Health Organization , Geneva, Switzerland
                Author notes
                [Correspondence to ] Dr Cheryl Johnson; johnsonc@ 123456who.int
                Author information
                http://orcid.org/0000-0002-7561-3368
                Article
                bmjopen-2022-071198
                10.1136/bmjopen-2022-071198
                10759095
                38154882
                e9aa96ce-964d-49cb-98f0-017b2111d2a4
                © World Health Organization 2023. Licensee BMJ.

                This is an open access article distributed under the terms of the Creative Commons Attribution IGO License ( CC BY 3.0 IGO), which permits use, distribution,and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.

                History
                : 22 December 2022
                : 08 November 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000865, Bill and Melinda Gates Foundation;
                Award ID: INV-024432
                Categories
                Health Policy
                1506
                1703
                Original research
                Custom metadata
                unlocked

                Medicine
                health policy,hiv & aids,diagnostic microbiology
                Medicine
                health policy, hiv & aids, diagnostic microbiology

                Comments

                Comment on this article